24Mar/21
PROTAC, a Frontier Small Molecule Drug
On December 14, 2020, Arvinas, a pioneer of PROTAC, announced the results of phase I clinical trials of new PROTAC drugs ARV-471 and ARV-110, of which ARV-471 showed outstanding efficacy in patientsRead More…